Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer. A Multicenter Phase Ib Trial (RECAP)
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2017
At a glance
- Drugs Regorafenib (Primary) ; Capecitabine
- Indications Rectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms RECAP
- 07 Nov 2017 Planned number of patients changed from 37 to 24.
- 24 Feb 2017 Status changed from not yet recruiting to recruiting.
- 29 Sep 2016 New trial record